Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of once-daily evening ciclesonide 160 µg with or without spacers in asthma
2005-002163-84Phase 3Completed
- Sponsor
- Altana Pharma
- Start
- Jun 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ciclesonide in asthma (3 arms), sponsored by Altana Pharma. Primary endpoints: Pulmonary function and Asthma control variables. Started Jun 2005; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-002163-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002163-84.